Latest Research Reports

PMDA approvals pivot to oncology

PMDA approvals pivot to oncology

Acute Myeloid Leukemia: noticeable differences in subtypes by age

Acute Myeloid Leukemia: noticeable differences in subtypes by age

A success story: the human papillomavirus vaccine

A success story: the human papillomavirus vaccine

Bispecific antibodies and CAR-T cells: A comparison of historical trial numbers and patient recruitment

Bispecific antibodies and CAR-T cells: A comparison of historical trial numbers and patient recruitment

Report: Newcomers set to capture market share from established players in Haemophilia A and B market by 2026

The haemophilia A and B market is projected to witness a substantial growth in the number of newcomers who will capture market share from established companies, according to a report by...

Report: Newcomers set to capture market share from established players in Haemophilia A and B market by 2026

Long-term effects of GHD treatment in children unclear

Long-term effects of GHD treatment in children unclear

Epidemiology of Heamophilia: a rare hereditary bleeding disorder

Epidemiology of Heamophilia: a rare hereditary bleeding disorder

Report: Acute myeloid leukaemia market to grow at CAGR of 14% by 2026

The acute myeloid leukaemia (AML) market is expected to triple from $406m in 2016 to more than $1.5bn by 2026, recording a compound annual growth rate (CAGR) of 14%, according to a report...

Report: Acute myeloid leukaemia market to grow at CAGR of 14% by 2026

Report: Global HER2-positive breast cancer market set to witness CAGR of 4.4%

The global human epidermal growth factor receptor type 2 (HER2)-positive breast cancer market is projected to grow from $6.4bn in 2015 to $9.89bn in 2025, witnessing a compound annual growth...

Report: Global HER2-positive breast cancer market set to witness CAGR of 4.4%

CGRP Antagonists forecast to dominate migraine market by 2026

CGRP Antagonists forecast to dominate migraine market by 2026

Report: Haemophilia A and B market set to reach $8bn by 2026

The haemophilia A and B market is projected to grow from $6.7bn in 2016 to $8bn in 2026 at a compound annual growth rate of 1.8%, according to a report by...

Report: Haemophilia A and B market set to reach $8bn by 2026

AbbVie’s Humira sales continue to climb beyond its patent expiration

AbbVie’s Humira sales continue to climb beyond its patent expiration

Top ten selling products of atrial fibrillation

Top ten selling products of atrial fibrillation

Generic sales erosion in neurology: the bigger they are, the harder they fall

Generic sales erosion in neurology: the bigger they are, the harder they fall

Risk of Venous thromboembolism higher in ageing population

Risk of Venous thromboembolism higher in ageing population

HER2 expression associated with poorer prognosis, but found more frequently in non-invasive breast cancer

HER2 expression associated with poorer prognosis, but found more frequently in non-invasive breast cancer

Burden of Diabetic Foot Ulcers

Burden of Diabetic Foot Ulcers

Importance of reducing the risk for Hepatitis C virus infection

Importance of reducing the risk for Hepatitis C virus infection

Report: Human immunodeficiency virus (HIV) market to reach $22.5bn by 2025

Long-acting therapies are anticipated to drive human immunodeficiency virus (HIV) market, according to a report by...

Report: Human immunodeficiency virus (HIV) market to reach $22.5bn by 2025

US Sees High Rates of Ovarian Cancer Diagnosed at Stage IV

US Sees High Rates of Ovarian Cancer Diagnosed at Stage IV

Type 2 Diabetes Leads Indications in Russian Clinical Trials, 2012-2016

Type 2 Diabetes Leads Indications in Russian Clinical Trials, 2012-2016